Aethlon Medical, Inc. (AEMD)

Market Cap	3.00M -49.2%
Revenue (ttm)	n/a
Net Income	-11.52M
EPS	-28.51
Shares Out	1.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	191,102
Open	2.070
Previous Close	2.130
Day's Range	1.910 - 2.130
52-Week Range	1.360 - 29.880
Beta	1.32
Analysts	Hold
Price Target	4.75 (+148.69%)
Earnings Date	Jun 10, 2026

About AEMD

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 9
• Stock Exchange: NASDAQ
• Ticker Symbol: AEMD
• Website: https://www.aethlonmedical.com

Analyst Summary

According to 2 analysts, the average rating for AEMD stock is "Hold." The 12-month stock price target is $4.75, which is an increase of 148.69% from the latest price.

Price Target

$4.75

(148.69% upside)

Analyst Consensus: Hold